Serialization experts will share best practices and practical applications at INTERPHEX 2015.
Is your company ready to meet the deadlines for US serialization? The first requirements of the Drug Supply Chain Security Act (DSCSA) came into effect on Jan. 1, 2015, although FDA extended the enforcement deadline for some transaction information requirements until May 1, 2015. Pharmaceutical Technology will host a panel of serialization experts on the Innovation Stage at Interphex on Tuesday, April 21, 2015, from 11:15 to noon, who will review the global regulations and share best practices for implementing serialization programs in the real world.
Many companies have already implemented systems that meet the DSCSA requirements. Bill Fletcher, managing partner of Pharma Logic Solutions, will share, "Deploying Serialization: Stories From the Front. Practical Lesson Learned While Deploying Serialization for Over 25 Life Sciences Manufacturers."
Experts are encouraging pharmaceutical companies to not put off developing and implementing a plan. Brian Daleiden, director of marketing at TraceLink, will present, "Three Emerging Trends and Why You Need to Start Now on Your Harmonized US Serialization and Global Track and Trace Strategy."
In 2017, DSCSA requires a unique identifier on saleable units and cases in both a human-readable code and a two-dimensional data-matrix code. Benoit Maheux, product manager and serialization team leader at Optel Vision, and Steve Peterson, project manager at CRB, a design, construction, and consulting firm, will discuss "Serialization Impacts in the Pharmaceuticals Industry: Case Studies in Unit-Level Serialization and Meeting DSCA 2017 Deadline."
Attendees at the Innovation Stage presentation will also hear from Martin Kuehn, VP of sales and marketing and Volker Ditscher, Track and Trace business manager at OCS Checkweighers; David Stirt from Vetter, which introduced a serialization service late in 2014; and Justin Schroder from PCI, which offers serialization technologies for its packaging services that meet requirements for various countries around the world.
Be sure to come to the Innovation Stage to hear these experts and to ask them your questions.
Legal and Regulatory Perspectives on 3D Printing: Drug Compounding Applications
December 10th 2024This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property rights.